Login
$ASH
$72.78 +$0.46 (0.64%) Close

$ASH SEC Filings

Filed On Filing
01 Oct 2026 Form 4: Bishop Steven D, Director

Granted 368 Common Stock Units ($25K)

01 Oct 2026 Form 4: Chattopadhyay Sanat, Director

Granted 212 Common Stock Units ($14.4K)

25 Sep 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

NOTE: In accordance with Item 601(a)(5) of Regulation S-K, this exhibit omits certain of its schedules and exhibits. This exhibit's table of contents includes a brief description of the subject matter of all of its schedules and exhibits...

23 Sep 2026 Form 4: Musa Osama M, SVP and CTO

Received 10,418 shares by exercise or conversion ($719K) · Gave up 3,647 shares to cover exercise price or tax ($252K)

16 Sep 2026 Form 4: Musa Osama M, SVP and CTO

Granted 14,230 Restricted Stock Unit

12 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 Form 4: Lampkin Robin E., SVP, GC & Secretary

Received 1,806 shares by exercise or conversion ($135K) · Gave up 526 shares to cover exercise price or tax ($39.2K) · Acquired 1,806 Restricted Stock Unit (Option Exercise/Conversion)

10 Aug 2026 8-K/A: Departure/Election of Directors or Officers; Compensation

On August 7, 2026, the Board appointed Allen A. Spizzo to serve as a member of the Audit Committee and the Sustainability & Productivity Committee of the Board and appointed Peter T. Thomas to serve as a member of the Governance and Nomi...

05 Aug 2026 Form 4: Thomas Peter T, Director

Granted 978 Restricted Stock Units ($64.9K)

05 Aug 2026 Form 4: Spizzo Allen A, Director

Granted 978 Restricted Stock Units ($64.9K)

05 Aug 2026 Form 3: Spizzo Allen A, Director

No securities owned

05 Aug 2026 Form 3: Thomas Peter T, Director

Holds 4,500 shares of Common Stock

05 Aug 2026 SCHEDULE 13G
31 Jul 2026 SCHEDULE 13G
31 Jul 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
30 Jul 2026 Form 4: Musa Osama M, SVP and CTO

Received 1,267 shares by exercise or conversion ($73.4K)

29 Jul 2026 Form 4: Assis Alessandra Faccin, SVP and GM, Life Sciences

Received 3,215 shares by exercise or conversion ($213K) · Gave up 884 shares to cover exercise price or tax ($58.7K)

29 Jul 2026 10-Q
28 Jul 2026 SCHEDULE 13G
28 Jul 2026 8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support